Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc‑labelled nanocolloid does not adversely afect long‑term outcomes

Simple item page
dc.contributor.authorMurphy, S.
dc.date.accessioned2024-09-23T15:16:15Z
dc.date.available2024-09-23T15:16:15Z
dc.date.issued2024
dc.departmentBurns and Plastics
dc.identifier.citationRoshan, A., Pasha, T., Kounidas, G., Murphy, S., Aloj, L., Buscombe, J., Patel, A. & Durrani, A. 2024. Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc‑labelled nanocolloid does not adversely afect long‑term outcomes. Annals of Nuclear Medicine, (Online ahead of print).
dc.identifier.doi10.1007/s12149-024-01980-y
dc.identifier.eissn1864-6433
dc.identifier.issn0914-7187
dc.identifier.journalAnnals of Nuclear Medicine
dc.identifier.pmid39283536
dc.identifier.urihttps://hdl.handle.net/20.500.14265/4716
dc.language.isoen
dc.publisherSpringer
dc.subjectOncology
dc.subjectRadiotherapy
dc.titleNext day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc‑labelled nanocolloid does not adversely afect long‑term outcomes
dc.typearticle
Files
Collections
2024 MSE Authored Research